20-HETE

20-hete is a lipid of Fatty Acyls (FA) class. 20-hete is associated with abnormalities such as Cyst, Kidney Diseases, Kidney Failure, Chronic, Cystic Kidney Diseases and Simple renal cyst. The involved functions are known as Phosphorylation, inhibitors, Hypertrophy, Epithelial Cell Proliferation and Anabolism. 20-hete often locates in Mouse Kidney, Microsomes, Tissue membrane, Body tissue and Cytoplasmic matrix. The associated genes with 20-HETE are CYP4F3 gene, PKHD1 gene, Transgenes, P4HTM gene and CYP2E1 gene. The related lipids are Promega, enterodiol, Fatty Acids, hexanoic acid and U 73343. The related experimental models are Mouse Model, Knock-out, Streptozotocin Diabetes, Transgenic Model and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of 20-HETE, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 20-HETE?

20-HETE is suspected in Hypertensive disease, Renal tubular disorder, endothelial dysfunction, Renal glomerular disease, Ischemia, Cerebral Vasospasm and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 20-HETE

MeSH term MeSH ID Detail
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Reperfusion Injury D015427 65 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Hypotension D007022 41 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Per page 10 20 50 | Total 33

PubChem Associated disorders and diseases

What pathways are associated with 20-HETE

Lipid pathways are not clear in current pathway databases. We organized associated pathways with 20-HETE through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 20-HETE?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 20-HETE?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 20-HETE?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 20-HETE?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 20-HETE?

Mouse Model

Mouse Model are used in the study '20-HETE mediates proliferation of renal epithelial cells in polycystic kidney disease.' (Park F et al., 2008), Mouse Model are used in the study 'Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth.' (Alexanian A et al., 2009) and Mouse Model are used in the study 'Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.' (Harder DR and Roman RJ, 2006).

Knock-out

Knock-out are used in the study 'Effects of 20-HETE on Na+ transport and Na+ -K+ -ATPase activity in the thick ascending loop of Henle.' (Yu M et al., 2007) and Knock-out are used in the study 'Elevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosatetraenoic acid contribute to pressure natriuresis.' (Williams JM et al., 2007).

Streptozotocin Diabetes

Streptozotocin Diabetes are used in the study 'Deficient renal 20-HETE release in the diabetic rat is not the result of oxidative stress.' (Chen YJ et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with 20-HETE

Download all related citations
Per page 10 20 50 100 | Total 571
Authors Title Published Journal PubMed Link
Mapelli L et al. Granular Layer Neurons Control Cerebellar Neurovascular Coupling Through an NMDA Receptor/NO-Dependent System. 2017 J. Neurosci. pmid:28039371
Yi M et al. Functional characterization of a common CYP4F11 genetic variant and identification of functionally defective CYP4F11 variants in erythromycin metabolism and 20-HETE synthesis. 2017 Arch. Biochem. Biophys. pmid:28347661
Kizub IV et al. Involvement of gap junctions between smooth muscle cells in sustained hypoxic pulmonary vasoconstriction development: a potential role for 15-HETE and 20-HETE. 2016 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:26895643
Froogh G et al. Female-favorable attenuation of coronary myogenic constriction via reciprocal activations of epoxyeicosatrienoic acids and nitric oxide. 2016 Am. J. Physiol. Heart Circ. Physiol. pmid:27016584
Yi X et al. Interactions Among CYP2C8, EPHX2, and CYP4A11 Variants and CYP Plasma Metabolite Levels in Ischemic Stroke. 2016 J. Atheroscler. Thromb. pmid:27087514
Ziegler N et al. β-Catenin Is Required for Endothelial Cyp1b1 Regulation Influencing Metabolic Barrier Function. 2016 J. Neurosci. pmid:27559173
Garbacz WG et al. Hepatic Overexpression of CD36 Improves Glycogen Homeostasis and Attenuates High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance. 2016 Mol. Cell. Biol. pmid:27528620
Jackson WF Arteriolar oxygen reactivity: where is the sensor and what is the mechanism of action? 2016 J. Physiol. (Lond.) pmid:27324312
Dordea AC et al. Androgen-sensitive hypertension associated with soluble guanylate cyclase-α1 deficiency is mediated by 20-HETE. 2016 Am. J. Physiol. Heart Circ. Physiol. pmid:27199131
Dalmasso C et al. 20-HETE and CYP4A2 ω-hydroxylase contribute to the elevated blood pressure in hyperandrogenemic female rats. 2016 Am. J. Physiol. Renal Physiol. pmid:27194719
Gebremedhin D et al. Expression of CYP 4A ω-hydroxylase and formation of 20-hydroxyeicosatetreanoic acid (20-HETE) in cultured rat brain astrocytes. 2016 Prostaglandins Other Lipid Mediat. pmid:27174801
Chen L et al. 20-HETE contributes to ischemia-induced angiogenesis. 2016 Vascul. Pharmacol. pmid:27084395
Liao D et al. Interaction Between CYP4F2 rs2108622 and CPY4A11 rs9333025 Variants Is Significantly Correlated with Susceptibility to Ischemic Stroke and 20-Hydroxyeicosatetraenoic Acid Level. 2016 Genet Test Mol Biomarkers pmid:26959478
Lakhkar A et al. 20-HETE-induced mitochondrial superoxide production and inflammatory phenotype in vascular smooth muscle is prevented by glucose-6-phosphate dehydrogenase inhibition. 2016 Am. J. Physiol. Heart Circ. Physiol. pmid:26921441
Huang H et al. Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke. 2016 Prostaglandins Other Lipid Mediat. pmid:26747234
Zhu Y et al. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice. 2016 PLoS ONE pmid:26727266
Garcia V et al. 20-HETE Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-κB Translocation and Promoter Binding. 2016 J. Pharmacol. Exp. Ther. pmid:26699146
Yi X et al. CYP Genetic Variants, CYP Metabolite Levels, and Symptomatic Carotid Stenosis in Ischemic Stroke Patients. 2016 J. Atheroscler. Thromb. pmid:26686738
Steuck M et al. Food Polyphenol Apigenin Inhibits the Cytochrome P450 Monoxygenase Branch of the Arachidonic Acid Cascade. 2016 J. Agric. Food Chem. pmid:27933871
McCarthy ET et al. Ethanol at low concentrations protects glomerular podocytes through alcohol dehydrogenase and 20-HETE. 2015 Jan-Mar Prostaglandins Other Lipid Mediat. pmid:25447342
Garcia V et al. Androgen-induced hypertension in angiotensinogen deficient mice: role of 20-HETE and EETS. 2015 Jan-Mar Prostaglandins Other Lipid Mediat. pmid:25526688
Yuan ZX and Rapoport SI Transient postnatal fluoxetine decreases brain concentrations of 20-HETE and 15-epi-LXA4, arachidonic acid metabolites in adult mice. 2015 Prostaglandins Leukot. Essent. Fatty Acids pmid:26234927
Liu X et al. Contribution of epoxyeicosatrienoic acids to the cerebral blood flow response to hypoxemia. 2015 J. Appl. Physiol. pmid:25792716
Walkowska A et al. High salt intake increases blood pressure in normal rats: putative role of 20-HETE and no evidence on changes in renal vascular reactivity. 2015 Kidney Blood Press. Res. pmid:26067851
Shaik JS et al. 20-Hydroxyeicosatetraenoic Acid Inhibition by HET0016 Offers Neuroprotection, Decreases Edema, and Increases Cortical Cerebral Blood Flow in a Pediatric Asphyxial Cardiac Arrest Model in Rats. 2015 J. Cereb. Blood Flow Metab. pmid:26058691
Althurwi HN et al. Early Changes in Cytochrome P450s and Their Associated Arachidonic Acid Metabolites Play a Crucial Role in the Initiation of Cardiac Hypertrophy Induced by Isoproterenol. 2015 Drug Metab. Dispos. pmid:26033621
Garcia V et al. Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension. 2015 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:25924878
Donnelly MK et al. 20-HETE is associated with unfavorable outcomes in subarachnoid hemorrhage patients. 2015 J. Cereb. Blood Flow Metab. pmid:25920956
Vanella L et al. Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis. 2015 Prostaglandins Other Lipid Mediat. pmid:25908301
Wang J et al. 20-Hydroxyeicosatetraenoic acid involved in endothelial activation and thrombosis. 2015 Am. J. Physiol. Heart Circ. Physiol. pmid:25820395
Hoopes SL et al. Vascular actions of 20-HETE. 2015 Prostaglandins Other Lipid Mediat. pmid:25813407
Zhu J et al. Additive Neuroprotection of a 20-HETE Inhibitor with Delayed Therapeutic Hypothermia after Hypoxia-Ischemia in Neonatal Piglets. 2015 Dev. Neurosci. pmid:25721266
Muroya Y et al. Deficiency in the Formation of 20-Hydroxyeicosatetraenoic Acid Enhances Renal Ischemia-Reperfusion Injury. 2015 J. Am. Soc. Nephrol. pmid:25644108
Fan F et al. Impaired myogenic response and autoregulation of cerebral blood flow is rescued in CYP4A1 transgenic Dahl salt-sensitive rat. 2015 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:25540098
Fan F et al. Cytochrome P450 eicosanoids in hypertension and renal disease. 2015 Curr. Opin. Nephrol. Hypertens. pmid:25427230
Siler DA et al. Protective role of p450 epoxyeicosanoids in subarachnoid hemorrhage. 2015 Neurocrit Care pmid:25231529
Gangadhariah MH et al. Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy. 2015 J. Am. Soc. Nephrol. pmid:25071086
Alvarellos ML et al. PharmGKB summary: very important pharmacogene information for CYP4F2. 2015 Pharmacogenet. Genomics pmid:25370453
Wu CC et al. 20-HETE and blood pressure regulation: clinical implications. 2014 Jan-Feb Cardiol Rev pmid:23584425
Bajpai P et al. Targeting of splice variants of human cytochrome P450 2C8 (CYP2C8) to mitochondria and their role in arachidonic acid metabolism and respiratory dysfunction. 2014 J. Biol. Chem. pmid:25160618
Chen L et al. Role of TRPV1 channels in ischemia/reperfusion-induced acute kidney injury. 2014 PLoS ONE pmid:25330307
Jarrar YB et al. Determination of major UDP-glucuronosyltransferase enzymes and their genotypes responsible for 20-HETE glucuronidation. 2014 J. Lipid Res. pmid:25249502
Ge Y et al. Role of 20-HETE in the impaired myogenic and TGF responses of the Af-Art of Dahl salt-sensitive rats. 2014 Am. J. Physiol. Renal Physiol. pmid:25007877
Sari AN et al. Effects of 5,14-HEDGE, a 20-HETE mimetic, on lipopolysaccharide-induced changes in MyD88/TAK1/IKKβ/IκB-α/NF-κB pathway and circulating miR-150, miR-223, and miR-297 levels in a rat model of septic shock. 2014 Inflamm. Res. pmid:24915805
Li X et al. 20-Hydroxyeicosatetraenoic acid impairs endothelial insulin signaling by inducing phosphorylation of the insulin receptor substrate-1 at Ser616. 2014 PLoS ONE pmid:24763529
Althurwi HN et al. Fenofibrate modulates cytochrome P450 and arachidonic acid metabolism in the heart and protects against isoproterenol-induced cardiac hypertrophy. 2014 J. Cardiovasc. Pharmacol. pmid:24157956
Ren Y et al. Mechanism of impaired afferent arteriole myogenic response in Dahl salt-sensitive rats: role of 20-HETE. 2014 Am. J. Physiol. Renal Physiol. pmid:24990891
Zhang Y et al. Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition. 2014 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:24990856
Hall CN et al. Capillary pericytes regulate cerebral blood flow in health and disease. 2014 Nature pmid:24670647
Chen L et al. 20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo. 2014 J. Pharmacol. Exp. Ther. pmid:24403517
Lu S et al. Effect of 20-hydroxyeicosatetraenoic acid on biological behavior of human villous trophoblasts and uterine vascular smooth muscle cells. 2014 Mol Med Rep pmid:24604088
Tse MM et al. Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line. 2013 May-Jun Vascul. Pharmacol. pmid:23466634
Eid S et al. Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy. 2013 Jul-Sep J. Biol. Regul. Homeost. Agents pmid:24152838
Imig JD Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function. 2013 Jul-Aug Prostaglandins Other Lipid Mediat. pmid:23333581
Tunctan B et al. NS-398 reverses hypotension in endotoxemic rats: contribution of eicosanoids, NO, and peroxynitrite. 2013 Jul-Aug Prostaglandins Other Lipid Mediat. pmid:22975359
Tunctan B et al. 5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: contribution of soluble epoxide hydrolase, CYP2C23, MEK1/ERK1/2/IKKβ/IκB-α/NF-κB pathway, and proinflammatory cytokine formation. 2013 Apr-May Prostaglandins Other Lipid Mediat. pmid:23454652
Ge Y et al. Endogenously produced 20-HETE modulates myogenic and TGF response in microperfused afferent arterioles. 2013 Apr-May Prostaglandins Other Lipid Mediat. pmid:23500064
Toth P et al. Treatment with the cytochrome P450 ω-hydroxylase inhibitor HET0016 attenuates cerebrovascular inflammation, oxidative stress and improves vasomotor function in spontaneously hypertensive rats. 2013 Br. J. Pharmacol. pmid:23194285
Eid S et al. 20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway. 2013 PLoS ONE pmid:23936373
Ding Y et al. 20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension. 2013 Am. J. Physiol. Renal Physiol. pmid:23825080
Lukaszewicz KM et al. Introgression of Brown Norway CYP4A genes on to the Dahl salt-sensitive background restores vascular function in SS-5(BN) consomic rats. 2013 Clin. Sci. pmid:22938512
Schuck RN et al. Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients. 2013 Atherosclerosis pmid:23466098
Anwar-Mohamed A et al. Acute arsenic treatment alters cytochrome P450 expression and arachidonic acid metabolism in lung, liver and kidney of C57Bl/6 mice. 2013 Xenobiotica pmid:23409951
Lukaszewicz KM and Lombard JH Role of the CYP4A/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive rat. 2013 Clin. Sci. pmid:23438293
Filosa JA and Iddings JA Astrocyte regulation of cerebral vascular tone. 2013 Am. J. Physiol. Heart Circ. Physiol. pmid:23792684
Edson KZ and Rettie AE CYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activities. 2013 Curr Top Med Chem pmid:23688133
Alsaad AM et al. Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy. 2013 Drug Metab. Rev. pmid:23600686
Wu CC et al. Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. 2013 J. Am. Soc. Nephrol. pmid:23641057
Orozco LD et al. 20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries. 2013 J. Pharmacol. Exp. Ther. pmid:23658377
Ngo AT et al. Significance of K(ATP) channels, L-type Ca²⁺ channels and CYP450-4A enzymes in oxygen sensing in mouse cremaster muscle arterioles in vivo. 2013 BMC Physiol. pmid:23663730
Li H and Zhu Y [Progress of studies in 20-hydroxyeicosatetraenoic acid on vascular endothelium]. 2013 Sheng Li Ke Xue Jin Zhan pmid:23671992
Li Y et al. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer. 2013 Toxicol. Appl. Pharmacol. pmid:23747687
Kim DH et al. Cyclooxygenase-2 dependent metabolism of 20-HETE increases adiposity and adipocyte enlargement in mesenchymal stem cell-derived adipocytes. 2013 J. Lipid Res. pmid:23293373
Lima R et al. Roles played by 20-HETE, angiotensin II and endothelin in mediating the hypertension in aging female spontaneously hypertensive rats. 2013 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:23220478
Fordsmann JC et al. Increased 20-HETE synthesis explains reduced cerebral blood flow but not impaired neurovascular coupling after cortical spreading depression in rat cerebral cortex. 2013 J. Neurosci. pmid:23392684
Issan Y et al. Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia. 2013 Prostaglandins Other Lipid Mediat. pmid:23291334
Jiang H et al. Maternal and fetal epoxyeicosatrienoic acids in normotensive and preeclamptic pregnancies. 2013 Am. J. Hypertens. pmid:23382413
Hadfield J et al. Modeling secondary messenger pathways in neurovascular coupling. 2013 Bull. Math. Biol. pmid:23358799
Wu J et al. Synergistical effect of 20-HETE and high salt on NKCC2 protein and blood pressure via ubiquitin-proteasome pathway. 2013 Hum. Genet. pmid:23104236
Han Y et al. 20-Hydroxyeicosatetraenoic acid mediates isolated heart ischemia/reperfusion injury by increasing NADPH oxidase-derived reactive oxygen species production. 2013 Circ. J. pmid:23585488
Kunduri SS et al. Adenosine A1 receptors link to smooth muscle contraction via CYP4a, protein kinase C-α, and ERK1/2. 2013 J. Cardiovasc. Pharmacol. pmid:23519140
Elshenawy OH et al. 20-Hydroxyeicosatetraenoic acid is a potential therapeutic target in cardiovascular diseases. 2013 Curr. Drug Metab. pmid:23701160
Ma F et al. Indapamide lowers blood pressure by increasing production of epoxyeicosatrienoic acids in the kidney. 2013 Mol. Pharmacol. pmid:23729436
Toth P et al. Role of 20-HETE, TRPC channels, and BKCa in dysregulation of pressure-induced Ca2+ signaling and myogenic constriction of cerebral arteries in aged hypertensive mice. 2013 Am. J. Physiol. Heart Circ. Physiol. pmid:24097425
Bubb KJ et al. Activation of neuronal transient receptor potential vanilloid 1 channel underlies 20-hydroxyeicosatetraenoic acid-induced vasoactivity: role for protein kinase A. 2013 Hypertension pmid:23753406
Fan F et al. 20-Hydroxyeicosatetraenoic acid contributes to the inhibition of K+ channel activity and vasoconstrictor response to angiotensin II in rat renal microvessels. 2013 PLoS ONE pmid:24324797
Van Bogaert I et al. Preparation of 20-HETE using multifunctional enzyme type 2-negative Starmerella bombicola. 2013 J. Lipid Res. pmid:23966667
Toth P et al. Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension. 2013 J. Cereb. Blood Flow Metab. pmid:23942363
Alexanian A et al. 20-HETE-producing enzymes are up-regulated in human cancers. 2012 Jul-Aug Cancer Genomics Proteomics pmid:22798501
Singh TU et al. Arachidonic acid inhibits Na⁺-K⁺-ATPase via cytochrome P-450, lipoxygenase and protein kinase C-dependent pathways in sheep pulmonary artery. 2012 Jan-Feb Vascul. Pharmacol. pmid:22155164
Regner KR and Roman RJ Role of medullary blood flow in the pathogenesis of renal ischemia-reperfusion injury. 2012 Curr. Opin. Nephrol. Hypertens. pmid:22080855
Lai G et al. Evaluation of CMV and KAP promoters for driving the expression of human CYP4F2 in transgenic mice. 2012 Int. J. Mol. Med. pmid:21887457
Vasudevan H et al. Testosterone-dependent increase in blood pressure is mediated by elevated Cyp4A expression in fructose-fed rats. 2012 Mol. Cell. Biochem. pmid:21894443
Liu X et al. Disturbed ratio of renal 20-HETE/EETs is involved in androgen-induced hypertension in cytochrome P450 4F2 transgenic mice. 2012 Gene pmid:22387726
Yu W et al. Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer. 2012 Toxicol. Appl. Pharmacol. pmid:22841774
Plée-Gautier E et al. Statins increase cytochrome P450 4F3-mediated eicosanoids production in human liver cells: a PXR dependent mechanism. 2012 Biochem. Pharmacol. pmid:22634049
Fernandez MM et al. Inhibitors of 20-hydroxyeicosatetraenoic acid (20-HETE) formation attenuate the natriuretic effect of dopamine. 2012 Eur. J. Pharmacol. pmid:22575524
Yang ZJ et al. Attenuation of neonatal ischemic brain damage using a 20-HETE synthesis inhibitor. 2012 J. Neurochem. pmid:22251169
Wen H et al. 20-Hydroxyeicosatetraenoic acid (20-HETE) is a novel activator of transient receptor potential vanilloid 1 (TRPV1) channel. 2012 J. Biol. Chem. pmid:22389490
Tunctan B et al. A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, nitric oxide, and 20-hydroxyeicosatetraenoic acid. 2012 Antiinflamm Antiallergy Agents Med Chem pmid:23013331